These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24468719)

  • 1. Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties.
    Gallant MA; Brown DM; Hammond M; Wallace JM; Du J; Deymier-Black AC; Almer JD; Stock SR; Allen MR; Burr DB
    Bone; 2014 Apr; 61():191-200. PubMed ID: 24468719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
    Surowiec RK; Saldivar R; Rai RK; Metzger CE; Jacobson AM; Allen MR; Wallace JM
    Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN; Aref MW; Gupta A; McNerny EMB; Brown D; Wallace JM; Allen MR
    Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene prevents skeletal fragility in adult female Zucker Diabetic Sprague-Dawley rats.
    Hill Gallant KM; Gallant MA; Brown DM; Sato AY; Williams JN; Burr DB
    PLoS One; 2014; 9(9):e108262. PubMed ID: 25243714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone.
    Allen MR; Hogan HA; Hobbs WA; Koivuniemi AS; Koivuniemi MC; Burr DB
    Endocrinology; 2007 Aug; 148(8):3908-13. PubMed ID: 17478550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
    Newman CL; Creecy A; Granke M; Nyman JS; Tian N; Hammond MA; Wallace JM; Brown DM; Chen N; Moe SM; Allen MR
    Kidney Int; 2016 Jan; 89(1):95-104. PubMed ID: 26489025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.
    Kimura S; Saito M; Kida Y; Seki A; Isaka Y; Marumo K
    Osteoporos Int; 2017 Mar; 28(3):1109-1119. PubMed ID: 27796444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism.
    Yan MZ; Xu Y; Gong YX; Liu JM; Lu SY; Huang L; Wang ZG; Zhao YJ; Pang XF
    Endocrine; 2010 Feb; 37(1):55-61. PubMed ID: 20963556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
    Berman AG; Wallace JM; Bart ZR; Allen MR
    Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
    Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
    PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference point indentation is insufficient for detecting alterations in traditional mechanical properties of bone under common experimental conditions.
    Krege JB; Aref MW; McNerny E; Wallace JM; Organ JM; Allen MR
    Bone; 2016 Jun; 87():97-101. PubMed ID: 27072518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immersion in Raloxifene does not significantly improve bone toughness or screw pull-out strength in multiple in vitro models.
    Eby MR; Cristino DM; Counihan M; Masada KM; Ahn J; Hast MW
    BMC Musculoskelet Disord; 2021 May; 22(1):468. PubMed ID: 34022860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raloxifene enhances vertebral mechanical properties independent of bone density.
    Allen MR; Iwata K; Sato M; Burr DB
    Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of 17beta-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice.
    Cano A; Dapía S; Noguera I; Pineda B; Hermenegildo C; del Val R; Caeiro JR; García-Pérez MA
    Osteoporos Int; 2008 Jun; 19(6):793-800. PubMed ID: 17968609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of raloxifene on bone turnover markers and bone mineral density in women on maintenance hemodialysis.
    Saito O; Saito T; Asakura S; Sugase T; Ito C; Ando Y; Muto S; Kusano E
    Clin Exp Nephrol; 2011 Feb; 15(1):126-31. PubMed ID: 21069410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD).
    Surowiec RK; Reul ON; Chowdhury NN; Rai RK; Segvich D; Tomaschke AA; Damrath J; Jacobson AM; Allen MR; Wallace JM
    Bone; 2024 Jun; 183():117089. PubMed ID: 38575047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose tacrolimus coadministered with raloxifene on the skeletal system in male rats.
    Folwarczna J; Kaczmarczyk-Sedlak I; Pytlik M; Nowińska B; Cegieła U; Sliwiński L; Janiec W; Trzeciak H; Trzeciak HI
    Acta Pol Pharm; 2009; 66(2):207-12. PubMed ID: 19719057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining anabolic loading and raloxifene improves bone quantity and some quality measures in a mouse model of osteogenesis imperfecta.
    Creecy A; Segvich D; Metzger C; Kohler R; Wallace JM
    Bone; 2024 Jul; 184():117106. PubMed ID: 38641232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural features underlying raloxifene's biophysical interaction with bone matrix.
    Bivi N; Hu H; Chavali B; Chalmers MJ; Reutter CT; Durst GL; Riley A; Sato M; Allen MR; Burr DB; Dodge JA
    Bioorg Med Chem; 2016 Feb; 24(4):759-67. PubMed ID: 26795112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone.
    Powell KM; Skaggs C; Pulliam A; Berman A; Allen MR; Wallace JM
    Bone; 2019 Oct; 127():199-206. PubMed ID: 31233931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.